The American Cannabis Operator Index added on to its 30.8% gain in January, rising 4.2% to 105.31 in February:
The index, which launched at the end of October with a value of 100, traded as low as 70.64 in late December after having reached a closing high of 124.16 in early November and has now rebounded 49.1% from the December 24th low:
During February, the index included 22 companies, including 17 multi-state operators (MSOs) and 5 focused solely on CBD extracted from industrial hemp. Several MSOs are pursuing CBD strategies apart from their state-licensed cannabis businesses. 7 companies managed double-digit gains, while 4 posted double-digit losses:
The three best performers included Chicago-based MSOs Cresco Labs (CSE: CL) (OTC: CRLBF) and Green Thumb Industries (CSE: GTII) (OTC: GTBIF) along with Curaleaf Holdings (CSE: CURA) (OTC: CURLF). MedMen Enterprises (CSE: MMEN) (OTC: MMNFF) led the way lower, and several companies focused on CBD from industrial hemp weighed on the index as well, including CV Sciences (OTC:CVSI), Isodiol International (CSE: ISOL) (OTC: ISOLF) and Charlotte’s Web (CSE: CWEB) (OTC: CWBHF)
For March, the index will include 23 names, as Cannex Holdings (CSE: CNNX) (OTC: CNXXF), Dixie Brands (CSE: DIXI) (OTC: DXBRF) and Halo Labs (NEO: HALO) (OTC: AGEEF), enter for the first time. We also removed GB Sciences (OTC: GBLX) due the decline in quarterly sales below the $1 million minimum and Golden Leaf Holdings (CSE: GLH) (OTC: GLDFF) due the decline in price below the $0.10 minimum.
In the next monthly review, we will summarize the performance for March and discuss any additions or deletions. Be sure to bookmark the page to stay current on American cannabis operators stock price movements within the day or from day-to-day.
Get ahead of the crowd by signing up for 420 Investor when it becomes available again. It’s the largest & most comprehensive premium service for cannabis investors since 2013.